A systematic review and meta-analysis of anti-pseudomonal penicillins and carbapenems in pediatric febrile neutropenia

Supportive Care in Cancer

Volumn 20, Issue 10, 2012, Pages 2295-2304

  Manji, Arif ^a   Lehrnbecher, Thomas ^b   Dupuis, L Lee ^a   Beyene, Joseph ^a,c,d   Sung, Lillian ^a,b,d  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^c MCMASTER UNIVERSITY   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

Antibiotics; Cancer; Children; Febrile neutropenia; Meta analysis

Indexed keywords

AMIKACIN; CARBAPENEM; IMIPENEM; MEROPENEM; PENICILLIN G; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM;

CHILD; FEBRILE NEUTROPENIA; HIGH RISK PATIENT; HUMAN; META ANALYSIS; MONOTHERAPY; MORTALITY; OBSERVATIONAL STUDY; PEDIATRICS; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; QUALITY CONTROL; REVIEW; SYSTEMATIC REVIEW; TREATMENT FAILURE;

ANTI-BACTERIAL AGENTS; BACTERIA; CARBAPENEMS; CHILD; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; FEVER; HUMANS; NEUTROPENIA; PENICILLINS; PROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 84868505460     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-011-1333-3     Document Type: Review

References (41)

1. Ahmed N, El-Mahallawy HA, Ahmed IA, Nassif S, El-Beshlawy A, El-Haddad A (2007) Early hospital discharge versus continued hospitalization in febrile pediatric cancer patients with prolonged neutropenia: a randomized, prospective study. Pediatr Blood Cancer 49:786-792 (Pubitemid 47519513)
2. Aksoylar S, Cetingul N, Kantar M, Karapinar D, Kavakli K, Kansoy S (2004) Meropenem plus amikacin versus piperacillin-tazobactam plus netilmicin as empiric therapy for high-risk febrile neutropenia in children. Pediatr Hematol Oncol 21:115-123 (Pubitemid 38313727)
3. Berger C, Kindli K, Niggli FK, Nadal D (2004) Withholding initial vancomycin in febrile neutropenia despite implanted catheters. Eur J Pediatr 163:422-423 (Pubitemid 38916385)
4. Bodey GP, Buckley M, Sathe YS, Freireich EJ (1966) Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 64:328-340
5. Bolton-Maggs PH, van Saene HK, McDowell HP, Martin J (1991) Clinical evaluation of ticarcillin, with clavulanic acid, and gentamicin in the treatment of febrile episodes in neutropenic children. J Antimicrob Chemother 27:669-676
6. Corapcioglu F, Sarper N, Zengin E (2006) Monotherapy with piperacillin/tazobactam versus cefepime as empirical therapy for febrile neutropenia in pediatric cancer patients: a randomized comparison. Pediatr Hematol Oncol 23:177-186 (Pubitemid 43361800)
7. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177-188 (Pubitemid 17189972)
8. Duzova A, Kutluk T, Kanra G et al (2001) Monotherapy with meropenem versus combination therapy with piperacillin plus amikacin as empiric therapy for neutropenic fever in children with lymphoma and solid tumors. Turk J Pediatr 43:105-109 (Pubitemid 32537265)
9. El Haddad AMA (1995) Comparison of cefoperazone-sulbactam versus piperacillin plus amikacin as empiric therapy in pediatric febrile neutropenic cancer patients. Curr Ther Res Clin Exp 56 (10):1094-1099
10. Fleischhack G, Hartmann C, Simon A et al (2001) Meropenem versus ceftazidime as empirical monotherapy in febrile neutropenia of paediatric patients with cancer. J Antimicrob Chemother 47:841-853 (Pubitemid 32519833)
11. Fleischhack G, Schmidt-Niemann M, Wulff B et al (2001) Piperacillin, beta-lactam inhibitor plus gentamicin as empirical therapy of a sequential regimen in febrile neutropenia of pediatric cancer patients. Support Care Cancer 9:372-379 (Pubitemid 32666889)
12. Freifeld AG, Bow EJ, Sepkowitz KA et al (2011) Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 52:e56-e93
13. Furno P, Bucaneve G, Del Favero A (2002) Monotherapy or aminoglycoside-containing combinations for empirical antibiotic treatment of febrile neutropenic patients: a meta-analysis. Lancet Infect Dis 2:231-242 (Pubitemid 34464753)
14. Gonzalez M, Clavell LA (1987) Piperacillin and gentamicin as non toxic empirical therapy in pediatric patients with fever and neutropenia. P R Health Sci J 6:13-15
15. Hamidah A, Rizal AM, Nordiah AJ, Jamal R (2008) Piperacillin- tazobactam plus amikacin as an initial empirical therapy of febrile neutropenia in paediatric cancer patients. Singapore Med J 49:26- 30 (Pubitemid 351239867)
16. Hayden JA, Cote P, Bombardier C (2006) Evaluation of the quality of prognosis studies in systematic reviews. Ann Intern Med 144:427-437 (Pubitemid 46768164)
17. Hemsworth S, Nunn AJ, Selwood K, Osborne C, Jones A, Pizer B (2005) Once-daily netilmicin for neutropenic pyrexia in paediatric oncology. Acta Paediatr 94:268-274
18. Heney D, Lewis IJ, Ghoneim AT, Chisholm P, Bailey CC (1991) Aztreonam therapy in children with febrile neutropenia: a randomized trial of aztreonam plus flucloxacillin versus piperacillin plus gentamicin. J Antimicrob Chemother 28:117-129
19. Hung KC, Chiu HH, Tseng YC et al (2003) Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empirical therapy for neutropenic fever in children with malignancy. J Microbiol Immunol Infect 36:254-259
20. Kim PW, Wu YT, Cooper C et al (2010) Meta-analysis of a possible signal of increased mortality associated with cefepime use. Clin Infect Dis 51:381-389
21. Klastersky J, Paesmans M, Rubenstein EB et al (2000) The Multinational Association for Supportive Care in Cancer risk index: a multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J Clin Oncol 18:3038-3051 (Pubitemid 30644129)
22. Kutluk T, Kurne O, Akyuz C et al (2004) Cefepime vs. meropenem as empirical therapy for neutropenic fever in children with lymphoma and solid tumours. Pediatr Blood Cancer 42:284-286 (Pubitemid 38235082)
23. Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159-174 (Pubitemid 8054849)
24. Miranda-Novales MG, Belmont-Martinez L, Villasis-Keever MA, Penagos-Paniagua M, Bernaldez-Rios R, Solorzano-Santos F (1998) Empirical antimicrobial therapy in pediatric patients with neutropenia and fever. Risk factors for treatment failure. Arch Med Res 29:331-335 (Pubitemid 29004967)
25. Morgan G, Duerden BI, Lilleyman JS (1983) Ceftazidime as a single agent in the management of children with fever and neutropenia. J Antimicrob Chemother 12(Suppl A):347-351 (Pubitemid 13001010)
26. Oguz A, Karadeniz C, Citak EC, Cil V, Eldes N (2006) Experience with cefepime versus meropenem as empiric monotherapy for neutropenia and fever in pediatric patients with solid tumors. Pediatr Hematol Oncol 23:245-253 (Pubitemid 43361806)
27. Pancharoen C, Mekmullica J, Buranachonapa J et al (2003) Efficacy and safety of meropenem as an empirical treatment for febrile neutropenia in children with cancer. J Med Assoc Thai 86(Suppl 2):S174-S178 (Pubitemid 37039495)
28. Paul M, Soares-Weiser K, Leibovici L (2003) Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for fever with neutropenia: systematic review and meta-analysis. BMJ 326:1111
29. Paul M, Yahav D, Bivas A, Fraser A, Leibovici L (2010) Antipseudomonal beta-lactams for the initial, empirical, treatment of febrile neutropenia: comparison of beta-lactams. Cochrane Database Syst Rev: CD005197
30. Petrilli AS, Cypriano M, Dantas LS et al (2003) Evaluation of ticarcillin/clavulanic acid versus ceftriaxone plus amikacin for fever and neutropenia in pediatric patients with leukemia and lymphoma. Braz J Infect Dis 7:111-120
31. Pizzo PA (1993) Management of fever in patients with cancer and treatment-induced neutropenia. N Engl J Med 328:1323-1332
32. Riikonen P (1991) Imipenem compared with ceftazidime plus vancomycin as initial therapy for fever in neutropenic children with cancer. Pediatr Infect Dis J 10:918-923
33. Schimpff S, Satterlee W, Young VM, Serpick A (1971) Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia. N Engl J Med 284:1061-1065
34. Shenep JL, Hughes WT, Roberson PK et al (1988) Vancomycin, ticarcillin, and amikacin compared with ticarcillin-clavulanate and amikacin in the empirical treatment of febrile, neutropenic children with cancer. N Engl J Med 319:1053-1058
35. Smith L, Will AM, Williams RF, Stevens RF (1990) Ceftriaxone vs. azlocillin and netilmicin in the treatment of febrile neutropenic children. J Infect 20:201-206 (Pubitemid 20184393)
36. Sung L, Phillips R, Lehrnbecher T (2011) Time for paediatric febrile neutropenia guidelines - children are not little adults. Eur J Cancer 47:811-813
37. Uygun V, Karasu GT, Ogunc D, Yesilipek A, Hazar V (2009) Piperacillin/tazobactam versus cefepime for the empirical treatment of pediatric cancer patients with neutropenia and fever: a randomized and open-label study. Pediatr Blood Cancer 53:610- 614
38. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP (2008) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 61:344-349 (Pubitemid 351289042)
39. Vural S, Erdem E, Gulec SG, Yildirmak Y, Kebudi R (2010) Imipenem-cilastatin versus piperacillin-tazobactam as monotherapy in febrile neutropenia. Pediatr Int 52:262-267
40. Yildirim I, Aytac S, Ceyhan M et al (2008) Piperacillin/tazobactam plus amikacin versus carbapenemmonotherapy as empirical treatment of febrile neutropenia in childhood hematological malignancies. Pediatr Hematol Oncol 25:291-299 (Pubitemid 351877035)
41. Zulfikar B, Devecioglu O, Anak S, Ovali F, Gedikoglu G (1991) The efficacy of mezlocillin-amikacin combination in febrile neutropenic children with oncologic disease. J Chemother 3:250-254